Rigel Pharmaceuticals (RIGL) Assets Average (2011 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Assets Average of $509.1 million for Q1 2026, up 199.52% year-over-year from $170.0 million in Q1 2025, and up 34.66% quarter-over-quarter from $378.1 million in Q4 2025.
Rigel Pharmaceuticals (RIGL) Assets Average (2011 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Assets Average history runs 16 years deep, the most recent figure standing at $509.1 million for Q1 2026.
- In Q1 2026, Assets Average rose 199.52% year-over-year to $509.1 million; the TTM figure through Mar 2026 stood at $509.1 million (up 199.52% YoY), while the FY2025 annual figure was $338.8 million, up 140.96% from the prior year.
- Assets Average for Q1 2026 stood at $509.1 million, up from $378.1 million in the prior quarter.
- The five-year high for Assets Average was $509.1 million in Q1 2026, with the low at $116.2 million in Q3 2023.
- The 5-year median for Assets Average is $133.9 million (2024), against an average of $178.4 million.
- The sharpest annual moves came in 2022 and 2026: Assets Average sank 37.23% in 2022, then surged 199.52% in 2026.
- Rigel Pharmaceuticals' Assets Average stood at $124.9 million in 2022, then retreated by 6.94% to $116.3 million in 2023, then jumped by 30.46% to $151.7 million in 2024, then surged by 149.22% to $378.1 million in 2025, then jumped by 34.66% to $509.1 million in 2026.
- Business Quant data shows RIGL's Assets Average at $509.1 million in Q1 2026, $378.1 million in Q4 2025, and $224.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn | 512.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 512.84 Mn |
| Mar 31, 2026 | 509.10 Mn |
| Dec 31, 2025 | 378.06 Mn |
| Sep 30, 2025 | 224.64 Mn |
| Jun 30, 2025 | 191.35 Mn |
| Mar 31, 2025 | 169.97 Mn |
| Dec 31, 2024 | 151.70 Mn |
| Sep 30, 2024 | 133.91 Mn |
| Jun 30, 2024 | 127.46 Mn |
| Mar 31, 2024 | 121.87 Mn |
| Dec 31, 2023 | 116.27 Mn |
| Sep 30, 2023 | 116.21 Mn |
| Jun 30, 2023 | 120.35 Mn |
| Mar 31, 2023 | 128.95 Mn |
| Dec 31, 2022 | 124.94 Mn |
| Sep 30, 2022 | 121.81 Mn |
| Jun 30, 2022 | 138.54 Mn |
| Mar 31, 2022 | 158.20 Mn |
| Dec 31, 2021 | 176.92 Mn |
| Sep 30, 2021 | 194.06 Mn |